GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
- Conditions
- Restless Legs Syndrome
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 48
- Registration Number
- NCT00422994
- Locations
- 🇬🇧
GSK Investigational Site, London, United Kingdom
Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 60
- Registration Number
- NCT00422604
- Locations
- 🇬🇧
GSK Investigational Site, Manchester, United Kingdom
Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy.
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2016-09-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 36
- Registration Number
- NCT00422955
- Locations
- 🇳🇱
GSK Investigational Site, Nijmegen, Netherlands
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
- Conditions
- Neoplasms, Breast
- Interventions
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 92
- Registration Number
- NCT00422903
- Locations
- 🇪🇸
GSK Investigational Site, Badalona, Spain
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
- Conditions
- Infections, PapillomavirusPapillomavirus Vaccines
- Interventions
- Biological: GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)Biological: Gardasil ® (Merck & Co. Inc)Biological: Placebo
- First Posted Date
- 2007-01-17
- Last Posted Date
- 2020-01-02
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1106
- Registration Number
- NCT00423046
- Locations
- 🇺🇸
GSK Investigational Site, Wenatchee, Washington, United States
Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 133
- Registration Number
- NCT00421707
- Locations
- 🇨🇦
GSK Investigational Site, Saskatoon, Saskatchewan, Canada
A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.
- Conditions
- AnalgesiaSedation
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2018-04-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 164
- Registration Number
- NCT00421720
- Locations
- 🇩🇪
GSK Clinical Trials Call Center, Tubingen, Germany
Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter
- Conditions
- Benign Prostatic Hyperplasia
- First Posted Date
- 2007-01-12
- Last Posted Date
- 2007-11-27
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 276
- Registration Number
- NCT00421421
- Locations
- 🇬🇧
GSK Clinical Trials Call Centre, Derby, United Kingdom
🇬🇧GSK Clinical Trials Call Center, Wakefield, United Kingdom
To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants
- Conditions
- Infections, Rotavirus
- Interventions
- Biological: Rotarix™Biological: Placebo
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1009
- Registration Number
- NCT00420745
- Locations
- 🇪🇸
GSK Investigational Site, Valladolid, Spain
MDD POC Study GSK372475 Subjects Depressive Disease
- Conditions
- Depressive Disorder
- Interventions
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 492
- Registration Number
- NCT00420641
- Locations
- 🇵🇱
GSK Investigational Site, Leszno, Poland